While deregulated BCL6 is linked to lymphomagenesis by suppressing DNA damage response and blocking terminal differentiation [27], increased BCL6 in the placenta, observed independently by several groups [20-24], contributes to the development of preeclampsia by impairing trophoblast differentiation and fusion. Here, BCL6 is linked to preeclampsia.